October 17, 2017 10:21 AM EDT
News Briefing

Boston biotech re­cruits Sanofi’s US can­cer re­search chief; Syn­dax in-li­cens­es Al­ler­gan port­fo­lio

John Carroll

Editor & Founder

→Boston-based Sil­i­con Ther­a­peu­tics has re­cruit­ed Sanofi’s US can­cer R&D chief Christo­pher Win­ter to come over and run the R&D side of the busi­ness. Sil­i­con …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bris­tol My­ers prunes pipeline amid new round of cost cuts

Pfiz­er hires No­var­tis on­col­o­gy ex­ec to steer its can­cer am­bi­tions

As­traZeneca takes $753M charge on aban­doned com­ple­ment drug from Alex­ion deal

Up­dat­ed: Hos­pi­tal group blasts pro­posed 340B re­bate mod­els, re­quests to join law­suits with HHS

J&J, In­tra-Cel­lu­lar quick­ly sealed $14B deal as three oth­ers passed on buy­ing the neu­ro drug­mak­er

Up­dat­ed: Lil­ly posts 45% sales jump, culls four pro­grams across obe­si­ty, Alzheimer's, heart fail­ure and eczema

A service from the Financial Times